Company Filing History:
2 out of 169 
1 out of 893 
1 out of 832,843 Years Active: 2000-2007
Title: Yulia Rozen: Innovator in Radiolabeled Inhibitors
Introduction
Yulia Rozen is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of medicinal radioimaging and radiotherapy. With a total of 3 patents, her work focuses on the development of radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase.
Latest Patents
Yulia's latest patents include innovative methods for utilizing radiolabeled epidermal growth factor receptor tyrosine kinase (EGFR-TK) irreversible inhibitors. These patents disclose their use as biomarkers for medicinal radioimaging techniques such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT). Additionally, these inhibitors serve as radiopharmaceuticals for radiotherapy, showcasing their potential in advancing cancer treatment.
Career Highlights
Throughout her career, Yulia has worked with Hadasit Medical Research Services and Development Ltd. Her expertise in the field has led to groundbreaking advancements in the application of radiolabeled compounds in medical imaging and therapy.
Collaborations
Yulia has collaborated with notable professionals in her field, including Eyal Yosef Mishani and Alexander Levitzki. These partnerships have contributed to her innovative research and development efforts.
Conclusion
Yulia Rozen's work in the development of radiolabeled irreversible inhibitors has positioned her as a key figure in the field of medicinal radioimaging and radiotherapy. Her contributions continue to influence advancements in cancer treatment and diagnostic imaging.